Transmucosal Drug Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report Download FREE Resources

Published: September 26, 2024 Report Code: GDME1833EPD-ST

Select Item

Transmucosal Drug Delivery Pipeline Market Report Overview

A transmucosal drug delivery device is intended for the localized delivery of medications through a mucous membrane. The transmucosal drug delivery pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·       Nasal

·       Vaginal

·       Buccal delivery

·       Rectal
Key Territories ·       The US

·       Europe

·       Australia

·       Canada

·       The UK
Key Regulatory Paths ·       510(k)

·       CE

·       PMA

·       TGA

·       UKCA
Leading Companies ·       AFYX Therapeutics A/S

·       Albert Einstein College of Medicine

·       Allergan Ltd

·       Altamira Medica AG

·       Amphastar Pharmaceuticals Inc
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Transmucosal Drug Delivery Pipeline Market by Segments

The key segments of the transmucosal drug delivery pipeline market are nasal, vaginal, buccal delivery, and rectal. As of September 2024, transmucosal drug delivery through the nose accounted for the highest share of pipeline products.

Transmucosal Drug Delivery Pipeline Market Analysis by Segments, 2024 (%)

Transmucosal Drug Delivery Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Transmucosal Drug Delivery Pipeline Market

Download a Free Report Sample

Transmucosal Drug Delivery Pipeline Market Segmentation by Territories

A few of the key territories with the transmucosal drug delivery pipeline market are the US, Europe, Australia, Canada, and the UK. As of September 2024, the US accounted for the highest number of pipeline products.

Transmucosal Drug Delivery Pipeline Market Analysis by Territories, 2024 (%)

Transmucosal Drug Delivery Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Transmucosal Drug Delivery Pipeline Market

Download a Free Report Sample

Transmucosal Drug Delivery Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the transmucosal drug delivery pipeline products market are 510(k), CE, PMA, TGA, and UKCA. As of September 2024, 510(k) was the most followed pathway for pipeline products in the transmucosal drug delivery market.

Transmucosal Drug Delivery Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Transmucosal Drug Delivery Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Transmucosal Drug Delivery Pipeline Market

Download a Free Report Sample

Transmucosal Drug Delivery Pipeline Market – Competitive Landscape

A few of the key companies associated with the transmucosal drug delivery pipeline market are AFYX Therapeutics A/S, Albert Einstein College of Medicine, Allergan Ltd, Altamira Medica AG, and Amphastar Pharmaceuticals Inc., among others.

Albert Einstein College of Medicine (AECM): Headquartered in Bronx, New York, the US, AECM is a subsidiary of Montefiore Health System Inc. This healthcare service provider offers educational services and operates as a research institute for medical education, basic research, and clinical investigation. It offers education programs such as graduate medical education, graduate programs, and masters in bioethics, among others.

Allergan Ltd (Allergan): Headquartered in Dublin, Ireland, it is a subsidiary of AbbVie Inc. This specialty pharmaceutical company develops and markets branded pharmaceuticals and biosimilar, and over-the-counter (OTC) pharmaceutical products. The company offers products in the areas of eye care, medical esthetics, dermatology, central nervous system, and others. It sells its products to retailers, drug wholesalers, distributors, mail-order retailers, and others.

Transmucosal Drug Delivery Pipeline Market Analysis by Companies, 2024

Transmucosal Drug Delivery Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Transmucosal Drug Delivery Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Transmucosal Drug Delivery Pipeline Market Segments Outlook (2024)

  • Nasal
  • Vaginal
  • Buccal delivery
  • Rectal

Transmucosal Drug Delivery Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • Australia
  • Canada
  • The UK

Transmucosal Drug Delivery Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE
  • PMA
  • TGA
  • UKCA

Scope

This report provides:

  • Extensive coverage of the transmucosal drug delivery under development.

  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of transmucosal drug delivery and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of transmucosal drug delivery under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

AFYX Therapeutics A/S
Albert Einstein College of Medicine
Allergan Ltd
Altamira Medica AG
Amphastar Pharmaceuticals Inc
Anelleo Inc
Aquestive Therapeutics Inc
Arovella Therapeutics Ltd
ARS Pharmaceuticals Inc
Atossa Therapeutics Inc
Auris Medical AG
Auritec Pharmaceuticals Inc
BeFree!
Bespak Europe Ltd
Biorings LLC
BioXcel Therapeutics Inc
Birmingham Biotech Ltd
Bryn Pharma LLC
Callitas Therapeutics Inc (Inactive)
Chulalongkorn University
Combinent BioMedical Systems Inc
Conrad
Covidrops LLP
CS Medica A/S
Dare Bioscience Inc
Eledon Pharmaceuticals Inc
Emergent BioSolutions Inc
EmphyCorp Inc
Ena Respiratory Pty Ltd
Eureka Therapeutics Inc
Eveon SAS
Evestra Inc
Evofem Biosciences Inc
Ferring Pharmaceuticals AS
Firebrick Pharma Pty Ltd
GeneOne Life Science Inc
Ghent University
Glenmark Pharmaceuticals Ltd
Grasses of Eden Ltd
Grunenthal Ltd
Halberd Corp
Hebrew University of Jerusalem
Hikma Pharmaceuticals Plc
Hovione FarmaCiencia SA
Imbed Biosciences Inc
Indivior Plc
Institute for Research and Innovation in Health
Insys Therapeutics Inc (Inactive)
IntelGenx Corp
International Partnership For Microbicides
ITC Life Sciences and Technology Centre
ITF Pharma Inc
Janssen Sciences Ireland UC
Kane Biotech Inc
Karessa Pharma AB
Karp Lab
Kiora Pharmaceuticals Inc
Kurve Therapeutics Inc
Kytogenics Pharmaceuticals Inc
Laboratoire HRA Pharma SAS
Lachesis Biosciences Ltd
Leyden Laboratories BV
Lobe Sciences Ltd
Lyra Therapeutics Inc
Magee-Womens Research Institute
MassBiologics
McNeil AB
Medlab Clinical Ltd
Merck & Co Inc
Merck Serono SA
Milestone Pharmaceuticals USA Inc
Mucommune LLC
Mycrodose Therapeutics Inc
Mystic Pharmaceuticals Inc
Nanosys Inc
Nasus Medical Inc
Nasus Pharma Ltd
Nemera La Verpilliere
NorInvent AB
Novlead Biotechnology Co Ltd
Olfax LLC
Opiant Pharmaceuticals Inc
OptiNose AS
OptiNose Inc
Organon Pharma (UK) Ltd
Orion Biotechnology Canada Ltd
Orphanse Healthcare SAS
Oyster Point Pharma Inc
P&B Group
Palette Life Sciences AB
Parnell Pharmaceuticals Inc
pHOXBIO Ltd
Pocket Naloxone Corp
Polyrizon Ltd
RDD Pharma Ltd (Inactive)
Renown Pharmaceuticals Pvt Ltd
Rhinomed Ltd
Sanotize Research and Development Corp
Scientus Pharma Inc (Inactive)
Seelos Therapeutics, Inc.
Shin Nippon Biomedical Laboratories Ltd
SipNose
South Valley University
Starpharma Holdings Ltd
Talphera Inc
The Population Council Inc
The University of Texas at Austin Division of Housing and Food Service
Therakind Ltd
Transire Bio
Union Therapeutics AS
University of Kentucky
University of Louisville
University of Melbourne
University of North Carolina at Chapel Hill
University of Pittsburgh
University of South Florida
University of the Witwatersrand
University of Waterloo
Virpax Pharmaceuticals Inc
VistaGen Therapeutics Inc
Washington University in St Louis
Wellfully Ltd
Xlear Inc
Zydus Healthcare Ltd

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Transmucosal Drug Delivery Overview

3 Products under Development

3.1 Transmucosal Drug Delivery – Pipeline Products by Stage of Development

3.2 Transmucosal Drug Delivery – Pipeline Products by Segment

3.3 Transmucosal Drug Delivery – Pipeline Products by Territory

3.4 Transmucosal Drug Delivery – Pipeline Products by Regulatory Path

3.5 Transmucosal Drug Delivery – Pipeline Products by Estimated Approval Date

3.6 Transmucosal Drug Delivery – Ongoing Clinical Trials

4 Transmucosal Drug Delivery – Pipeline Products under Development by Companies

4.1 Transmucosal Drug Delivery Companies – Pipeline Products by Stage of Development

4.2 Transmucosal Drug Delivery – Pipeline Products by Stage of Development

5 Transmucosal Drug Delivery Companies and Product Overview

5.1 AFYX Therapeutics A/S Company Overview

5.1.1 AFYX Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview

5.2 Albert Einstein College of Medicine Company Overview

5.2.1 Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview

5.3 Allergan Ltd Company Overview

5.3.1 Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.4 Altamira Medica AG Company Overview

5.4.1 Altamira Medica AG Pipeline Products & Ongoing Clinical Trials Overview

5.5 Amphastar Pharmaceuticals Inc Company Overview

5.5.1 Amphastar Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.6 Anelleo Inc Company Overview

5.6.1 Anelleo Inc Pipeline Products & Ongoing Clinical Trials Overview

5.7 Aquestive Therapeutics Inc Company Overview

5.7.1 Aquestive Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.8 Arovella Therapeutics Ltd Company Overview

5.8.1 Arovella Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.9 ARS Pharmaceuticals Inc Company Overview

5.9.1 ARS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.10 Atossa Therapeutics Inc Company Overview

5.10.1 Atossa Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.11 Auris Medical AG Company Overview

5.11.1 Auris Medical AG Pipeline Products & Ongoing Clinical Trials Overview

5.12 Auritec Pharmaceuticals Inc Company Overview

5.12.1 Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.13 BeFree! Company Overview

5.13.1 BeFree! Pipeline Products & Ongoing Clinical Trials Overview

5.14 Bespak Europe Ltd Company Overview

5.14.1 Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.15 Biorings LLC Company Overview

5.15.1 Biorings LLC Pipeline Products & Ongoing Clinical Trials Overview

5.16 BioXcel Therapeutics Inc Company Overview

5.16.1 BioXcel Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.17 Birmingham Biotech Ltd Company Overview

5.17.1 Birmingham Biotech Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.18 Bryn Pharma LLC Company Overview

5.18.1 Bryn Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview

5.19 Callitas Therapeutics Inc (Inactive) Company Overview

5.19.1 Callitas Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.20 Chulalongkorn University Company Overview

5.20.1 Chulalongkorn University Pipeline Products & Ongoing Clinical Trials Overview

5.21 Combinent BioMedical Systems Inc Company Overview

5.21.1 Combinent BioMedical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

5.22 Conrad Company Overview

5.22.1 Conrad Pipeline Products & Ongoing Clinical Trials Overview

5.23 Covidrops LLP Company Overview

5.23.1 Covidrops LLP Pipeline Products & Ongoing Clinical Trials Overview

5.24 CS Medica A/S Company Overview

5.24.1 CS Medica A/S Pipeline Products & Ongoing Clinical Trials Overview

5.25 Dare Bioscience Inc Company Overview

5.25.1 Dare Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview

5.26 Eledon Pharmaceuticals Inc Company Overview

5.26.1 Eledon Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.27 Emergent BioSolutions Inc Company Overview

5.27.1 Emergent BioSolutions Inc Pipeline Products & Ongoing Clinical Trials Overview

5.28 EmphyCorp Inc Company Overview

5.28.1 EmphyCorp Inc Pipeline Products & Ongoing Clinical Trials Overview

5.29 Ena Respiratory Pty Ltd Company Overview

5.29.1 Ena Respiratory Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.30 Eureka Therapeutics Inc Company Overview

5.30.1 Eureka Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.31 Eveon SAS Company Overview

5.31.1 Eveon SAS Pipeline Products & Ongoing Clinical Trials Overview

5.32 Evestra Inc Company Overview

5.32.1 Evestra Inc Pipeline Products & Ongoing Clinical Trials Overview

5.33 Evofem Biosciences Inc Company Overview

5.33.1 Evofem Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

5.34 Ferring Pharmaceuticals AS Company Overview

5.34.1 Ferring Pharmaceuticals AS Pipeline Products & Ongoing Clinical Trials Overview

5.35 Firebrick Pharma Pty Ltd Company Overview

5.35.1 Firebrick Pharma Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.36 GeneOne Life Science Inc Company Overview

5.36.1 GeneOne Life Science Inc Pipeline Products & Ongoing Clinical Trials Overview

5.37 Ghent University Company Overview

5.37.1 Ghent University Pipeline Products & Ongoing Clinical Trials Overview

5.38 Glenmark Pharmaceuticals Ltd Company Overview

5.38.1 Glenmark Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.39 Grasses of Eden Ltd Company Overview

5.39.1 Grasses of Eden Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.40 Grunenthal Ltd Company Overview

5.40.1 Grunenthal Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.41 Halberd Corp Company Overview

5.41.1 Halberd Corp Pipeline Products & Ongoing Clinical Trials Overview

5.42 Hebrew University of Jerusalem Company Overview

5.42.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview

5.43 Hikma Pharmaceuticals Plc Company Overview

5.43.1 Hikma Pharmaceuticals Plc Pipeline Products & Ongoing Clinical Trials Overview

5.44 Hovione FarmaCiencia SA Company Overview

5.44.1 Hovione FarmaCiencia SA Pipeline Products & Ongoing Clinical Trials Overview

5.45 Imbed Biosciences Inc Company Overview

5.45.1 Imbed Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

5.46 Indivior Plc Company Overview

5.46.1 Indivior Plc Pipeline Products & Ongoing Clinical Trials Overview

5.47 Institute for Research and Innovation in Health Company Overview

5.47.1 Institute for Research and Innovation in Health Pipeline Products & Ongoing Clinical Trials Overview

5.48 Insys Therapeutics Inc (Inactive) Company Overview

5.48.1 Insys Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.49 IntelGenx Corp Company Overview

5.49.1 IntelGenx Corp Pipeline Products & Ongoing Clinical Trials Overview

5.50 International Partnership For Microbicides Company Overview

5.50.1 International Partnership For Microbicides Pipeline Products & Ongoing Clinical Trials Overview

5.51 ITC Life Sciences and Technology Centre Company Overview

5.51.1 ITC Life Sciences and Technology Centre Pipeline Products & Ongoing Clinical Trials Overview

5.52 ITF Pharma Inc Company Overview

5.52.1 ITF Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview

5.53 Janssen Sciences Ireland UC Company Overview

5.53.1 Janssen Sciences Ireland UC Pipeline Products & Ongoing Clinical Trials Overview

5.54 Kane Biotech Inc Company Overview

5.54.1 Kane Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview

5.55 Karessa Pharma AB Company Overview

5.55.1 Karessa Pharma AB Pipeline Products & Ongoing Clinical Trials Overview

5.56 Karp Lab Company Overview

5.56.1 Karp Lab Pipeline Products & Ongoing Clinical Trials Overview

5.57 Kiora Pharmaceuticals Inc Company Overview

5.57.1 Kiora Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.58 Kurve Therapeutics Inc Company Overview

5.58.1 Kurve Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.59 Kytogenics Pharmaceuticals Inc Company Overview

5.59.1 Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.60 Laboratoire HRA Pharma SAS Company Overview

5.60.1 Laboratoire HRA Pharma SAS Pipeline Products & Ongoing Clinical Trials Overview

5.61 Lachesis Biosciences Ltd Company Overview

5.61.1 Lachesis Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.62 Leyden Laboratories BV Company Overview

5.62.1 Leyden Laboratories BV Pipeline Products & Ongoing Clinical Trials Overview

5.63 Lobe Sciences Ltd Company Overview

5.63.1 Lobe Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.64 Lyra Therapeutics Inc Company Overview

5.64.1 Lyra Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.65 Magee-Womens Research Institute Company Overview

5.65.1 Magee-Womens Research Institute Pipeline Products & Ongoing Clinical Trials Overview

5.66 MassBiologics Company Overview

5.66.1 MassBiologics Pipeline Products & Ongoing Clinical Trials Overview

5.67 McNeil AB Company Overview

5.67.1 McNeil AB Pipeline Products & Ongoing Clinical Trials Overview

5.68 Medlab Clinical Ltd Company Overview

5.68.1 Medlab Clinical Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.69 Merck & Co Inc Company Overview

5.69.1 Merck & Co Inc Pipeline Products & Ongoing Clinical Trials Overview

5.70 Merck Serono SA Company Overview

5.70.1 Merck Serono SA Pipeline Products & Ongoing Clinical Trials Overview

5.71 Milestone Pharmaceuticals USA Inc Company Overview

5.71.1 Milestone Pharmaceuticals USA Inc Pipeline Products & Ongoing Clinical Trials Overview

5.72 Mucommune LLC Company Overview

5.72.1 Mucommune LLC Pipeline Products & Ongoing Clinical Trials Overview

5.73 Mycrodose Therapeutics Inc Company Overview

5.73.1 Mycrodose Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.74 Mystic Pharmaceuticals Inc Company Overview

5.74.1 Mystic Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.75 Nanosys Inc Company Overview

5.75.1 Nanosys Inc Pipeline Products & Ongoing Clinical Trials Overview

5.76 Nasus Medical Inc Company Overview

5.76.1 Nasus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.77 Nasus Pharma Ltd Company Overview

5.77.1 Nasus Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.78 Nemera La Verpilliere Company Overview

5.78.1 Nemera La Verpilliere Pipeline Products & Ongoing Clinical Trials Overview

5.79 NorInvent AB Company Overview

5.79.1 NorInvent AB Pipeline Products & Ongoing Clinical Trials Overview

5.80 Novlead Biotechnology Co Ltd Company Overview

5.80.1 Novlead Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.81 Olfax LLC Company Overview

5.81.1 Olfax LLC Pipeline Products & Ongoing Clinical Trials Overview

5.82 Opiant Pharmaceuticals Inc Company Overview

5.82.1 Opiant Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.83 OptiNose AS Company Overview

5.83.1 OptiNose AS Pipeline Products & Ongoing Clinical Trials Overview

5.84 OptiNose Inc Company Overview

5.84.1 OptiNose Inc Pipeline Products & Ongoing Clinical Trials Overview

5.85 Organon Pharma (UK) Ltd Company Overview

5.85.1 Organon Pharma (UK) Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.86 Orion Biotechnology Canada Ltd Company Overview

5.86.1 Orion Biotechnology Canada Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.87 Orphanse Healthcare SAS Company Overview

5.87.1 Orphanse Healthcare SAS Pipeline Products & Ongoing Clinical Trials Overview

5.88 Oyster Point Pharma Inc Company Overview

5.88.1 Oyster Point Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview

5.89 P&B Group Company Overview

5.89.1 P&B Group Pipeline Products & Ongoing Clinical Trials Overview

5.90 Palette Life Sciences AB Company Overview

5.90.1 Palette Life Sciences AB Pipeline Products & Ongoing Clinical Trials Overview

5.91 Parnell Pharmaceuticals Inc Company Overview

5.91.1 Parnell Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.92 pHOXBIO Ltd Company Overview

5.92.1 pHOXBIO Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.93 Pocket Naloxone Corp Company Overview

5.93.1 Pocket Naloxone Corp Pipeline Products & Ongoing Clinical Trials Overview

5.94 Polyrizon Ltd Company Overview

5.94.1 Polyrizon Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.95 RDD Pharma Ltd (Inactive) Company Overview

5.95.1 RDD Pharma Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.96 Renown Pharmaceuticals Pvt Ltd Company Overview

5.96.1 Renown Pharmaceuticals Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.97 Rhinomed Ltd Company Overview

5.97.1 Rhinomed Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.98 Sanotize Research and Development Corp Company Overview

5.98.1 Sanotize Research and Development Corp Pipeline Products & Ongoing Clinical Trials Overview

5.99 Scientus Pharma Inc (Inactive) Company Overview

5.99.1 Scientus Pharma Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.100 Seelos Therapeutics, Inc. Company Overview

5.100.1 Seelos Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.101 Shin Nippon Biomedical Laboratories Ltd Company Overview

5.101.1 Shin Nippon Biomedical Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.102 SipNose Company Overview

5.102.1 SipNose Pipeline Products & Ongoing Clinical Trials Overview

5.103 South Valley University Company Overview

5.103.1 South Valley University Pipeline Products & Ongoing Clinical Trials Overview

5.104 Starpharma Holdings Ltd Company Overview

5.104.1 Starpharma Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.105 Talphera Inc Company Overview

5.105.1 Talphera Inc Pipeline Products & Ongoing Clinical Trials Overview

5.106 The Population Council Inc Company Overview

5.106.1 The Population Council Inc Pipeline Products & Ongoing Clinical Trials Overview

5.107 The University of Texas at Austin Division of Housing and Food Service Company Overview

5.107.1 The University of Texas at Austin Division of Housing and Food Service Pipeline Products & Ongoing Clinical Trials Overview

5.108 Therakind Ltd Company Overview

5.108.1 Therakind Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.109 Transire Bio Company Overview

5.109.1 Transire Bio Pipeline Products & Ongoing Clinical Trials Overview

5.110 Union Therapeutics AS Company Overview

5.110.1 Union Therapeutics AS Pipeline Products & Ongoing Clinical Trials Overview

5.111 University of Kentucky Company Overview

5.111.1 University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview

5.112 University of Louisville Company Overview

5.112.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview

5.113 University of Melbourne Company Overview

5.113.1 University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview

5.114 University of North Carolina at Chapel Hill Company Overview

5.114.1 University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview

5.115 University of Pittsburgh Company Overview

5.115.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview

5.116 University of South Florida Company Overview

5.116.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview

5.117 University of the Witwatersrand Company Overview

5.117.1 University of the Witwatersrand Pipeline Products & Ongoing Clinical Trials Overview

5.118 University of Waterloo Company Overview

5.118.1 University of Waterloo Pipeline Products & Ongoing Clinical Trials Overview

5.119 Virpax Pharmaceuticals Inc Company Overview

5.119.1 Virpax Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.120 VistaGen Therapeutics Inc Company Overview

5.120.1 VistaGen Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.121 Washington University in St Louis Company Overview

5.121.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview

5.122 Wellfully Ltd Company Overview

5.122.1 Wellfully Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.123 Xlear Inc Company Overview

5.123.1 Xlear Inc Pipeline Products & Ongoing Clinical Trials Overview

5.124 Zydus Healthcare Ltd Company Overview

5.124.1 Zydus Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Transmucosal Drug Delivery- Recent Developments

6.1 Sep 19, 2024: Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra to Treat Migraines

6.2 Sep 11, 2024: Marinomed Biotech : First Carragelose Products Receive New Medical Device Regulation (MDR) Certification

6.3 Sep 09, 2024: Nasodine European Marketing Application Filed And Passed Validation

6.4 Sep 05, 2024: New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus Surgery

6.5 Sep 04, 2024: ARS Pharmaceuticals Launches Pre-Ordering Services for Neffy to Help Patients Access the First and Only Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis

6.6 Sep 04, 2024: Halberd Issues Letter to Shareholders – Patented LDN+ Evolves into WatchDawg for Veteran Suicide Reduction

6.7 Aug 26, 2024: Indivior Announces BARDA’s First Order of OPVEE to Combat Opioids and Aid in National Preparedness

6.8 Aug 23, 2024: Altamira Therapeutics Announces Extension of Bentrio Distribution Agreement with Pharma Nordic to Include Sweden and Denmark

6.9 Aug 15, 2024: New Agreement Allows Nasodine Launch in Philippines

6.10 Aug 15, 2024: Aptar’s Nasal Unidose System to Deliver neffy (epinephrine nasal spray), the First and Only FDA-Approved Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis

6.11 Aug 06, 2024: Emergent BioSolutions Expands NARCAN Nasal Spray Distribution Capabilities to Enhance Customer Delivery Experience Across the Country

6.12 Aug 05, 2024: Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024

6.13 Aug 02, 2024: Cambridge Biotherapies Set to Transform Lives with New Affordable Depression Treatment

6.14 Jul 24, 2024: Halberd Groundbreaking Traumatic Brain Injury (TBI) Mitigation Nasal Spray Shows Promising Phase II Initial Test Results

6.15 Jul 22, 2024: Emergent BioSolutions Announces Shelf-Life Extension for NARCAN Nasal Spray in Canada

6.16 Jul 19, 2024: Altamira Therapeutics Announces Publication Of Preclinical Data Showing Successful Treatment Of Abdominal Aortic Aneurysm With Sod2 Mrna Delivered By Semaphore Nanoparticles

6.17 Jul 17, 2024: Wild Theory CBD Unveils Latest Innovation, CBD Nasal Spray

6.18 Jul 15, 2024: Jessica Kahn, M.D., M.P.H., Named Senior Associate Dean for Clinical and Translational Research at Albert Einstein College of Medicine

6.19 Jul 10, 2024: The Population Council Appoints Dr. Rana Hajjeh as President

6.20 Jul 09, 2024: Vistagen Broadens PH80 Global Intellectual Property Portfolio with New Patents for the Treatment of Migraine

6.21 Jul 09, 2024: Vistagen Broadens PH80 Global Intellectual Property Portfolio with New Patents for the Treatment of Migraine

6.22 Jun 28, 2024: ARS Pharmaceuticals Announces EURneffy (adrenaline nasal spray) Recommended for Approval by CHMP for Emergency Treatment of Allergic Reactions (anaphylaxis)

6.23 Jun 18, 2024: Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)

6.24 May 23, 2024: Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal

6.25 May 22, 2024: Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California

6.26 May 02, 2024: Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024

6.27 Apr 26, 2024: Algipharma Presented at Lipid Nanoparticle Summit in Boston

6.28 Apr 24, 2024: Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal

6.29 Apr 24, 2024: Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose

6.30 Apr 18, 2024: Bayer is Recalling Two Lots of Hydrasense Baby Nasal Care Easydose Due to Potential Contamination

6.31 Apr 11, 2024: Neurelis Announces Two Poster Presentations at the 76th Annual Meeting of the American Academy of Neurology

6.32 Apr 11, 2024: Marinomed Biotech AG: Launch of New Allergen-Blocking Carragelose Product in Austria and Market Entry in Mexico

6.33 Apr 09, 2024: Clinical Trial Finds Nasal Spray Safely Treats Recurrent Abnormal Heart Rhythms

6.34 Apr 08, 2024: IntelGenx Announces First Parkinson’s Disease Patients Dosed with Montelukast VersaFilm in Phase 2 ‘MONTPARK’ Clinical Trial

6.35 Apr 08, 2024: Milestone Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage Recurring PSVT, Presented at The American College of Cardiology Annual Meeting

6.36 Apr 02, 2024: Bespak Confirms Completion of Inhaled and Nasal Drug Delivery Business Separation from Recipharm to Focus on the Transition to Low Gwp Pmdis

6.37 Mar 29, 2024: FDA Approves First Over-the-Counter Naloxone Nasal Spray

6.38 Mar 28, 2024: Milestone Pharmaceuticals Announces Resubmission of New Drug Application for Etripamil for Treatment in Paroxysmal Supraventricular Tachycardia

6.39 Mar 25, 2024: National Safety Council Expands Efforts to Combat Overdoses in the Workplace

6.40 Mar 21, 2024: Daré Bioscience to Host Full Year 2023 Financial Results and Company Update Conference Call and Webcast on March 28, 2024

6.41 Mar 15, 2024: Aptar Pharma announces capacity extension at Congers site

6.42 Mar 14, 2024: Gynica announces First-in-Human Clinical Trial of Novel IntraVag Treatment for Endometriosis

6.43 Mar 11, 2024: Indivior Announces Publication Demonstrating that OPVEE (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone

6.44 Mar 05, 2024: Study Finds No Safety Concerns When the Dapivirine Vaginal Ring Is Used during the Second and Third Trimesters of Pregnancy, According to Results Presented at CROI 2024

6.45 Mar 04, 2024: Renaissance Lakewood Invests in Additional High-Speed Nasal Spray Assembly and Packaging Capability

6.46 Feb 26, 2024: ARS Pharmaceuticals Announces Neffy Meets Primary Endpoints and Shows Rapid Symptom Control in Phase 2 Urticaria Clinical Study

6.47 Feb 26, 2024: Milestone Pharmaceuticals Announces Plan to Resubmit NDA for Etripamil for the Treatment of PSVT

6.48 Feb 22, 2024: Bryn Pharma to Present Positive Results from Three New Analyses Further Supporting Use of Its Epinephrine Nasal Spray in Adults at the 2024 AAAAI Annual Meeting

6.49 Feb 21, 2024: Renaissance Lakewood Breathing Excellence into Nasal Product R&D and Clinical Manufacturing

6.50 Feb 13, 2024: SaNOtize to Evaluate Nitric Oxide Nasal Spray for the Treatment of Sinusitis

6.51 Feb 08, 2024: Halberd and Mississippi State University to Commence Stage II Advanced TBI Nasal Spray Testing

6.52 Jan 29, 2024: Viraleze Shows Antiviral Efficacy in COVID-19 Patients

6.53 Jan 25, 2024: Cosmo Pharmaceuticals Announces Invitation to Investor Day and Full-Year 2023 Webcast – Zurich, 20 March 2024

6.54 Jan 18, 2024: Pressure BioSciences Reports New Client Launching Around UltraShear Nanoemulsions Platform with $300,000-plus Product Order

6.55 Jan 17, 2024: Dare Bioscience Announces Grant to Support Biotherapeutic Product Development

6.56 Dec 27, 2023: Firebrick Closes AAT Appeal

6.57 Dec 20, 2023: Harm Reduction Therapeutics Introduces RiVive, Over-the-Counter Opioid Overdose Reversal Medication

6.58 Dec 12, 2023: Positive Results from Pivotal Study for Bryn Pharma’s Investigational Epinephrine Nasal Spray Published in the Journal of Allergy and Clinical Immunology: Global

6.59 Dec 07, 2023: New Aptar Mumbai Site to Increase Manufacturing Capabilities

6.60 Dec 04, 2023: Aptar Awarded US FDA Contract to Study Opportunities for Low Global Warming Potential Propellants for Metered Dose Inhalers

6.61 Dec 01, 2023: Neurelis Announces Presentations at the American Epilepsy Society Annual Meeting

6.62 Nov 29, 2023: Nasodine COVID-19 Patent Granted in South Africa

6.63 Nov 29, 2023: Hovione Expands Nasal Drug Delivery Capabilities With the Development of Nasal Powder Delivery Device Technology in Collaboration With IDC

6.64 Nov 29, 2023: Lumen Bioscience Announces $5.5 Million Funding to Support New Research Program for Mucosal Vaccine Platform Technology

6.65 Nov 29, 2023: Hovione Expands Nasal Drug Delivery Capabilities with the Development of Nasal Powder Delivery Device Technology in Collaboration with IDC

6.66 Nov 28, 2023: Leveraging Nemera’s scientific expertise and continued effort in the nose-to-brain field

6.67 Nov 17, 2023: Altamira Therapeutics Announces Partial Spin-Off of Bentrio Business

6.68 Nov 15, 2023: Halberd Corporation Plans to Extend Research Partnership with Mississippi State University

6.69 Nov 09, 2023: Bryn Pharma to Present Positive Clinical Data Supporting Use of Its Epinephrine Nasal Spray in Adults with or without Congestion at 2023 ACAAI Annual Meeting

6.70 Nov 08, 2023: TFF Pharmaceuticals Announces Publication of Data Demonstrating Feasibility of Intranasal Delivery of Monoclonal Antibodies with Thin Film Freezing

6.71 Nov 07, 2023: Aptar Pharma to Showcase Key Innovations at Pharmapack 2024

6.72 Oct 31, 2023: Firebrick Receives $1.81m R&D Tax Incentive

6.73 Oct 12, 2023: Aptar Pharma Presents Webinar on Advancing Inhaled Nasal Drug Clinical Studies Insights and Strategies

6.74 Oct 09, 2023: Aptar Pharma Showcases Sustainability Focus at CPHI Barcelona

6.75 Oct 08, 2023: New Safety Data Suggests SPRAVATO is Effective Compared to Quetiapine Extended-Release with Treatment-resistant Major Depressive Disorder

6.76 Oct 06, 2023: ARS Pharmaceuticals Announces Scheduling of a Type A Meeting with the U.S. FDA for neffy (epinephrine nasal spray)

6.77 Oct 04, 2023: Halberd’s Traumatic Brain Injury (TBI) Testing Results Replicated at Mississippi State University (MSU)

6.78 Oct 03, 2023: Single and Repeat Dose Clinical Study of neffy (epinephrine nasal spray) Published in the Journal of Allergy and Clinical Immunology

6.79 Oct 03, 2023: Nemera reinforces commitment to sustainability with first integrated ESG report

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Transmucosal Drug Delivery – Pipeline Products by Stage of Development

Transmucosal Drug Delivery – Pipeline Products by Segment

Transmucosal Drug Delivery – Pipeline Products by Territory

Transmucosal Drug Delivery – Pipeline Products by Regulatory Path

Transmucosal Drug Delivery – Pipeline Products by Estimated Approval Date

Transmucosal Drug Delivery – Ongoing Clinical Trials

Transmucosal Drug Delivery Companies – Pipeline Products by Stage of Development

Transmucosal Drug Delivery – Pipeline Products by Stage of Development

AFYX Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview

Rivelin – CLO Patch – Product Status

Rivelin – CLO Patch – Product Description

Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview

Drug-Impregnated Intravaginal Ring – Product Status

Drug-Impregnated Intravaginal Ring – Product Description

Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview

Vaginal Ring – Product Status

Vaginal Ring – Product Description

Altamira Medica AG Pipeline Products & Ongoing Clinical Trials Overview

Bentrio – Viral Infections – Product Status

Bentrio – Viral Infections – Product Description

Altamira Medica AG – Ongoing Clinical Trials Overview

Bentrio – Viral Infections – A Randomized, Placebo-controlled Clinical Study to Evaluate the Ability of Bentrio Nasal Spray in COVID-19 Patients: COVAMID

Amphastar Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

Intranasal Naloxone Spray – OTC – Product Status

Intranasal Naloxone Spray – OTC – Product Description

Anelleo Inc Pipeline Products & Ongoing Clinical Trials Overview

AnelleO PRO – Product Status

AnelleO PRO – Product Description

Aquestive Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

Anaphylm – Product Status

Anaphylm – Product Description

Arovella Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview

ArTiMist – Product Status

ArTiMist – Product Description

ARS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

Neffy – Product Status

Neffy – Product Description

Atossa Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

AT-301 Nasal Spray – Product Status

AT-301 Nasal Spray – Product Description

Auris Medical AG Pipeline Products & Ongoing Clinical Trials Overview

AM-125 Betahistine Nasal Spray – Product Status

AM-125 Betahistine Nasal Spray – Product Description

AM-201 Betahistine Nasal Spray – Product Status

AM-201 Betahistine Nasal Spray – Product Description

Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

BUP Pod-IVR – Product Status

BUP Pod-IVR – Product Description

NuvaRing – Product Status

NuvaRing – Product Description

pod-IVR – Product Status

pod-IVR – Product Description

Pritelivir Intravaginal Ring – Product Status

Pritelivir Intravaginal Ring – Product Description

Versa Intravaginal Ring – Acromegaly – Product Status

Versa Intravaginal Ring – Acromegaly – Product Description

Versa Intravaginal Ring – Alzheimer’s Disease – Product Status

Versa Intravaginal Ring – Alzheimer’s Disease – Product Description

Versa Intravaginal Ring – Breast Cancer – Product Status

Versa Intravaginal Ring – Breast Cancer – Product Description

Versa Intravaginal Ring – Endometriosis – Product Status

Versa Intravaginal Ring – Endometriosis – Product Description

Versa Intravaginal Ring – Herpes – Product Status

Versa Intravaginal Ring – Herpes – Product Description

Versa Intravaginal Ring – HIV Prophylaxis – Product Status

Versa Intravaginal Ring – HIV Prophylaxis – Product Description

Versa Intravaginal Ring – Pain And Addiction – Product Status

Versa Intravaginal Ring – Pain And Addiction – Product Description

Versa Intravaginal Ring – Parkinson’s Disease – Product Status

Versa Intravaginal Ring – Parkinson’s Disease – Product Description

Versa Intravaginal Ring – Type II Diabetes – Product Status

Versa Intravaginal Ring – Type II Diabetes – Product Description

Versa Intravaginal Ring – Uterine Fibroids – Product Status

Versa Intravaginal Ring – Uterine Fibroids – Product Description

BeFree! Pipeline Products & Ongoing Clinical Trials Overview

Vaginal Drug Delivery System – Product Status

Vaginal Drug Delivery System – Product Description

Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview

NAS010 – Nasal Drug Delivery Device – Product Status

NAS010 – Nasal Drug Delivery Device – Product Description

NAS020 – Unidose Nasal Drug Delivery Device – Product Status

NAS020 – Unidose Nasal Drug Delivery Device – Product Description

NAS030 Nasal Device – Product Status

NAS030 Nasal Device – Product Description

Biorings LLC Pipeline Products & Ongoing Clinical Trials Overview

Vaginal Ring – Product Status

Vaginal Ring – Product Description

BioXcel Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

BXCL501 Sublingual Film – Product Status

BXCL501 Sublingual Film – Product Description

BioXcel Therapeutics Inc – Ongoing Clinical Trials Overview

BXCL501 Sublingual Film – A Study to Evaluate the BXCL501 for At-home Use in Patients with Bipolar Disorder or Schizophrenia

Birmingham Biotech Ltd Pipeline Products & Ongoing Clinical Trials Overview

BHM Anti-Viral Nasal Spray – Product Status

BHM Anti-Viral Nasal Spray – Product Description

Bryn Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview

BRYN-NDS1C – Product Status

BRYN-NDS1C – Product Description

Callitas Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

CannaMint Strip – Product Status

CannaMint Strip – Product Description

Chulalongkorn University Pipeline Products & Ongoing Clinical Trials Overview

AntiCov Nasal Spray – Product Status

AntiCov Nasal Spray – Product Description

Combinent BioMedical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

Multi-Segmented Vaginal Ring – Product Status

Multi-Segmented Vaginal Ring – Product Description

Conrad Pipeline Products & Ongoing Clinical Trials Overview

Multipurpose Prevention Intravaginal Ring – Product Status

Multipurpose Prevention Intravaginal Ring – Product Description

Topical Dual-Compartment Insert – Product Status

Topical Dual-Compartment Insert – Product Description

Vaginal Ring – HIV Protection – Product Status

Vaginal Ring – HIV Protection – Product Description

Covidrops LLP Pipeline Products & Ongoing Clinical Trials Overview

Nasal Spray – COVID-19 – Product Status

Nasal Spray – COVID-19 – Product Description

CS Medica A/S Pipeline Products & Ongoing Clinical Trials Overview

CANNASEN Nasal Night Spray – Product Status

CANNASEN Nasal Night Spray – Product Description

Dare Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview

DARE-FRT1 Intravaginal Ring – Product Status

DARE-FRT1 Intravaginal Ring – Product Description

DARE-HRT1 Intravaginal Ring – Product Status

DARE-HRT1 Intravaginal Ring – Product Description

DARE-OAB1 – Product Status

DARE-OAB1 – Product Description

DARE-VVA1 Intravaginal Ring – Product Status

DARE-VVA1 Intravaginal Ring – Product Description

Eledon Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

OP0201 – Product Status

OP0201 – Product Description

Emergent BioSolutions Inc Pipeline Products & Ongoing Clinical Trials Overview

SIAN – Product Status

SIAN – Product Description

EmphyCorp Inc Pipeline Products & Ongoing Clinical Trials Overview

N115 Non-Steroidal Nasal Spray – Product Status

N115 Non-Steroidal Nasal Spray – Product Description

Ena Respiratory Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

INNA-051 Nasal Spray – Product Status

INNA-051 Nasal Spray – Product Description

Eureka Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

InvisiMask Nasal Spray – Product Status

InvisiMask Nasal Spray – Product Description

Eveon SAS Pipeline Products & Ongoing Clinical Trials Overview

Dropper System – Product Status

Dropper System – Product Description

Evestra Inc Pipeline Products & Ongoing Clinical Trials Overview

EVE112 – Vaginal Ring – Product Status

EVE112 – Vaginal Ring – Product Description

EVE116 – Vaginal Ring – Product Status

EVE116 – Vaginal Ring – Product Description

EVE120 – Vaginal Ring – Product Status

EVE120 – Vaginal Ring – Product Description

EVE122 – Vaginal Ring – Product Status

EVE122 – Vaginal Ring – Product Description

Vaginal Ring For Preterm Labor – Product Status

Vaginal Ring For Preterm Labor – Product Description

Evofem Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

Amphora/QGriffithsin Fast-Dissolving Vaginal Insert – Product Status

Amphora/QGriffithsin Fast-Dissolving Vaginal Insert – Product Description

Ferring Pharmaceuticals AS Pipeline Products & Ongoing Clinical Trials Overview

C-Vad Vaginal Insert – Product Status

C-Vad Vaginal Insert – Product Description

Premis Vaginal Insert – Product Status

Premis Vaginal Insert – Product Description

Firebrick Pharma Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

Nasodine Nasal Spray – Adult – Product Status

Nasodine Nasal Spray – Adult – Product Description

Nasodine Nasal Spray – Junior – Product Status

Nasodine Nasal Spray – Junior – Product Description

GeneOne Life Science Inc Pipeline Products & Ongoing Clinical Trials Overview

GLS-1200 Nasal Spray – Product Status

GLS-1200 Nasal Spray – Product Description

Ghent University Pipeline Products & Ongoing Clinical Trials Overview

Vaginal DL-Lactic Acid Releasing Ring – Product Status

Vaginal DL-Lactic Acid Releasing Ring – Product Description

Glenmark Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview

Ryaltris Nasal Spray – Product Status

Ryaltris Nasal Spray – Product Description

Glenmark Pharmaceuticals Ltd – Ongoing Clinical Trials Overview

Ryaltris Nasal Spray – A Phase III Clinical Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Ryaltris Compound Nasal Spray for the Treatment of Allergic Rhinitis or Rhinoconjunctivitis Symptoms in Patients

Grasses of Eden Ltd Pipeline Products & Ongoing Clinical Trials Overview

Nasal Spray Device – Product Status

Nasal Spray Device – Product Description

Grunenthal Ltd Pipeline Products & Ongoing Clinical Trials Overview

Estradiol + Progesterone Vaginal Ring – Product Status

Estradiol + Progesterone Vaginal Ring – Product Description

Fertiring – Product Status

Fertiring – Product Description

Halberd Corp Pipeline Products & Ongoing Clinical Trials Overview

Halberd Nasal Spray – Product Status

Halberd Nasal Spray – Product Description

Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview

Buccal Drug Delivery Device – Oral Cavity Disorders – Product Status

Buccal Drug Delivery Device – Oral Cavity Disorders – Product Description

Hikma Pharmaceuticals Plc Pipeline Products & Ongoing Clinical Trials Overview

Buprenorphine/Naloxone Sublingual Spray – Product Status

Buprenorphine/Naloxone Sublingual Spray – Product Description

EpiPen – Product Status

EpiPen – Product Description

Hovione FarmaCiencia SA Pipeline Products & Ongoing Clinical Trials Overview

Multiple-Use Nasal Powder Device – Product Status

Multiple-Use Nasal Powder Device – Product Description

Single-Use Nasal Powder Device – Product Status

Single-Use Nasal Powder Device – Product Description

Imbed Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

Nasal Spray – Product Status

Nasal Spray – Product Description

Indivior Plc Pipeline Products & Ongoing Clinical Trials Overview

OPNT002 Opioid Antagonist Nasal Spray – Product Status

OPNT002 Opioid Antagonist Nasal Spray – Product Description

Institute for Research and Innovation in Health Pipeline Products & Ongoing Clinical Trials Overview

TFV/EFV Nanoparticle Vaginal Delivery System – Product Status

TFV/EFV Nanoparticle Vaginal Delivery System – Product Description

Insys Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Buprenorphine Sublingual Spray Device – Product Status

Buprenorphine Sublingual Spray Device – Product Description

Naloxone Sublingual Spray – Product Status

Naloxone Sublingual Spray – Product Description

Ondansetron Sublingual Spray – Product Status

Ondansetron Sublingual Spray – Product Description

IntelGenx Corp Pipeline Products & Ongoing Clinical Trials Overview

Montelukast VersaFilm – Product Status

Montelukast VersaFilm – Product Description

IntelGenx Corp – Ongoing Clinical Trials Overview

Montelukast VersaFilm – A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Use of Montelukast Versafilm for the Treatment of Parkinson’s Disease (PD)

International Partnership For Microbicides Pipeline Products & Ongoing Clinical Trials Overview

Dapivirine-Contraceptive Ring – Product Status

Dapivirine-Contraceptive Ring – Product Description

International Partnership For Microbicides – Ongoing Clinical Trials Overview

Dapivirine-Contraceptive Ring – A Randomized, Double-Blind, Phase 1b Study in Healthy HIV-Negative Women to Evaluate the Pharmacokinetics, Safety, and Bleeding Patterns Associated With 90-Day Use of Core-Sheath Vaginal Rings Releasing Dapivirine and Levonorgestrel

ITC Life Sciences and Technology Centre Pipeline Products & Ongoing Clinical Trials Overview

Savlon Nasal Spray – Product Status

Savlon Nasal Spray – Product Description

ITF Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview

Progesterone Vaginal Ring – Luteal Support – Product Status

Progesterone Vaginal Ring – Luteal Support – Product Description

Janssen Sciences Ireland UC Pipeline Products & Ongoing Clinical Trials Overview

DapiRing – Product Status

DapiRing – Product Description

Kane Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview

Nasal Spray – Chronic Sinusitis – Product Status

Nasal Spray – Chronic Sinusitis – Product Description

Karessa Pharma AB Pipeline Products & Ongoing Clinical Trials Overview

K-01 – Product Status

K-01 – Product Description

K-02 – Product Status

K-02 – Product Description

K-03 – Product Status

K-03 – Product Description

K-21 – Product Status

K-21 – Product Description

Karp Lab Pipeline Products & Ongoing Clinical Trials Overview

Nasal Spray – SARS-CoV-2 – Product Status

Nasal Spray – SARS-CoV-2 – Product Description

Kiora Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

EyeGate II Delivery System – Product Status

EyeGate II Delivery System – Product Description

Kurve Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

ViaNase – Corticosteroid – Product Status

ViaNase – Corticosteroid – Product Description

ViaNase – Insulin – Product Status

ViaNase – Insulin – Product Description

ViaNase – Polyclonal IgG – Product Status

ViaNase – Polyclonal IgG – Product Description

Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

Drug Delivery Device – Intestinal Cystitis – Product Status

Drug Delivery Device – Intestinal Cystitis – Product Description

Laboratoire HRA Pharma SAS Pipeline Products & Ongoing Clinical Trials Overview

UPA C-Ring – Product Status

UPA C-Ring – Product Description

Lachesis Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview

Rivamist Nasal Spray – Product Status

Rivamist Nasal Spray – Product Description

Leyden Laboratories BV Pipeline Products & Ongoing Clinical Trials Overview

Liquid Nasal Spray – Product Status

Liquid Nasal Spray – Product Description

Lobe Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview

Nasal Mist Device – Product Status

Nasal Mist Device – Product Description

Lyra Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

LYR-210 Transmucosal Delivery System – Product Status

LYR-210 Transmucosal Delivery System – Product Description

LYR-220 – Product Status

LYR-220 – Product Description

Lyra Therapeutics Inc – Ongoing Clinical Trials Overview

LYR-210 Transmucosal Delivery System – ENLIGHTEN 1: A Phase III, Randomized, Blinded, Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis (CRS) in Adults

LYR-210 Transmucosal Delivery System – ENLIGHTEN 2: A Phase III, Randomized, Blinded, Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults

Magee-Womens Research Institute Pipeline Products & Ongoing Clinical Trials Overview

EFdA-P+Progestin Intravaginal Film – Product Status

EFdA-P+Progestin Intravaginal Film – Product Description

MassBiologics Pipeline Products & Ongoing Clinical Trials Overview

mAb 2C7+TDF IVR – Product Status

mAb 2C7+TDF IVR – Product Description

McNeil AB Pipeline Products & Ongoing Clinical Trials Overview

Antiviral Polymeric Nasal Spray – Product Status

Antiviral Polymeric Nasal Spray – Product Description

Medlab Clinical Ltd Pipeline Products & Ongoing Clinical Trials Overview

NanaBis – Product Status

NanaBis – Product Description

Medlab Clinical Ltd – Ongoing Clinical Trials Overview

NanaBis – An Observational Study Investigating and Auditing the Safety, Tolerability and Further Efficacy Characteristics of a Pharmaceutical Grade Cannabis Medicine (NanaBis) Prescribed to Eligible Patients for the Management of Cancer Related or Non-cancer Related Pain in General and Specialty Medical Practices

Merck & Co Inc Pipeline Products & Ongoing Clinical Trials Overview

ENG-CVR – Product Status

ENG-CVR – Product Description

Merck Serono SA Pipeline Products & Ongoing Clinical Trials Overview

MK-8342 Medicated IUS – Product Status

MK-8342 Medicated IUS – Product Description

Milestone Pharmaceuticals USA Inc Pipeline Products & Ongoing Clinical Trials Overview

Cardamyst – Product Status

Cardamyst – Product Description

Mucommune LLC Pipeline Products & Ongoing Clinical Trials Overview

HCA+VRC01+N6 IVR – Product Status

HCA+VRC01+N6 IVR – Product Description

LA-Releasing Intravaginal Ring – Product Status

LA-Releasing Intravaginal Ring – Product Description

Non-Hormonal Contraceptive Intravaginal Ring – Product Status

Non-Hormonal Contraceptive Intravaginal Ring – Product Description

Mycrodose Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

Sublingual Drug Delivery System – LSD – Product Status

Sublingual Drug Delivery System – LSD – Product Description

Mystic Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

MystiFen – Product Status

MystiFen – Product Description

MystiZof – Product Status

MystiZof – Product Description

Nanosys Inc Pipeline Products & Ongoing Clinical Trials Overview

Gecko-Inspired Drug Delivery Device – Product Status

Gecko-Inspired Drug Delivery Device – Product Description

Nasus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Catheter-Based Atomization Drug Delivery Device – Product Status

Catheter-Based Atomization Drug Delivery Device – Product Description

Nasus Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview

FMXIN001 Naloxone Powder-Based Nasal Spray – Product Status

FMXIN001 Naloxone Powder-Based Nasal Spray – Product Description

Nemera La Verpilliere Pipeline Products & Ongoing Clinical Trials Overview

Electronic Nasal Device – Product Status

Electronic Nasal Device – Product Description

Nasal Vaccine Device – Product Status

Nasal Vaccine Device – Product Description

Safe’n’Spray – Product Status

Safe’n’Spray – Product Description

NorInvent AB Pipeline Products & Ongoing Clinical Trials Overview

XtriG Drug Delivery Device – Product Status

XtriG Drug Delivery Device – Product Description

Novlead Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

iNOfirst Antiviral Spray – Product Status

iNOfirst Antiviral Spray – Product Description

Olfax LLC Pipeline Products & Ongoing Clinical Trials Overview

Intranasal Delivery Device – Product Status

Intranasal Delivery Device – Product Description

Opiant Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

OPNT001 Opioid Antagonist Nasal Spray – Product Status

OPNT001 Opioid Antagonist Nasal Spray – Product Description

OptiNose AS Pipeline Products & Ongoing Clinical Trials Overview

OptiNose Bi-Directional Breath Powered Orexin-A Delivery Device – Product Status

OptiNose Bi-Directional Breath Powered Orexin-A Delivery Device – Product Description

OptiNose Inc Pipeline Products & Ongoing Clinical Trials Overview

Optinose Exhalation Delivery Device – Product Status

Optinose Exhalation Delivery Device – Product Description

Organon Pharma (UK) Ltd Pipeline Products & Ongoing Clinical Trials Overview

Etonogestrel + 17ß-Estradiol Vaginal Ring – Product Status

Etonogestrel + 17ß-Estradiol Vaginal Ring – Product Description

Orion Biotechnology Canada Ltd Pipeline Products & Ongoing Clinical Trials Overview

OB-002 IVR – Product Status

OB-002 IVR – Product Description

Orphanse Healthcare SAS Pipeline Products & Ongoing Clinical Trials Overview

ORH01 Drug Delivery Device – Product Status

ORH01 Drug Delivery Device – Product Description

Oyster Point Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview

Tyrvaya Nasal Spray – Product Status

Tyrvaya Nasal Spray – Product Description

P&B Group Pipeline Products & Ongoing Clinical Trials Overview

ADW S-100 Ionized Water Nasal Spray – Product Status

ADW S-100 Ionized Water Nasal Spray – Product Description

Palette Life Sciences AB Pipeline Products & Ongoing Clinical Trials Overview

Lidbree – Product Status

Lidbree – Product Description

Parnell Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

Nomovid Nasal Spray – Product Status

Nomovid Nasal Spray – Product Description

pHOXBIO Ltd Pipeline Products & Ongoing Clinical Trials Overview

pHOXWELL – Product Status

pHOXWELL – Product Description

Pocket Naloxone Corp Pipeline Products & Ongoing Clinical Trials Overview

Intranasal Spray – Naloxone – Product Status

Intranasal Spray – Naloxone – Product Description

Polyrizon Ltd Pipeline Products & Ongoing Clinical Trials Overview

Intranasal Delivery System – Product Status

Intranasal Delivery System – Product Description

RDD Pharma Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Capository – Product Status

Capository – Product Description

Renown Pharmaceuticals Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

Sub-Lingual Apomorphine Spray – Product Status

Sub-Lingual Apomorphine Spray – Product Description

Rhinomed Ltd Pipeline Products & Ongoing Clinical Trials Overview

Intranasal Drug Delivery Device – Acute Migraine – Product Status

Intranasal Drug Delivery Device – Acute Migraine – Product Description

Sanotize Research and Development Corp Pipeline Products & Ongoing Clinical Trials Overview

Fabispray – Product Status

Fabispray – Product Description

Sanotize Research and Development Corp – Ongoing Clinical Trials Overview

Fabispray – A Study to Evaluate the Safety and Efficacy of Nitric Oxide Nasal Spray (Fabispray) in the Treatment of Recurrent Acute Rhinosinusitis

Scientus Pharma Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

RapidMist Buccal Delivery System – Product Status

RapidMist Buccal Delivery System – Product Description

Seelos Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

SLS-002 Intranasal Device – Product Status

SLS-002 Intranasal Device – Product Description

Shin Nippon Biomedical Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview

µco System – Product Status

µco System – Product Description

SipNose Pipeline Products & Ongoing Clinical Trials Overview

Cribriform Targeted Device – Product Status

Cribriform Targeted Device – Product Description

South Valley University Pipeline Products & Ongoing Clinical Trials Overview

Ivermectin Nasal Spray – Product Status

Ivermectin Nasal Spray – Product Description

Starpharma Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview

Viraleze Nasal Spray – Product Status

Viraleze Nasal Spray – Product Description

Talphera Inc Pipeline Products & Ongoing Clinical Trials Overview

Zalviso – Product Status

Zalviso – Product Description

The Population Council Inc Pipeline Products & Ongoing Clinical Trials Overview

EEQ Intravaginal Ring – Product Status

EEQ Intravaginal Ring – Product Description

Intravaginal Ring – Product Status

Intravaginal Ring – Product Description

The University of Texas at Austin Division of Housing and Food Service Pipeline Products & Ongoing Clinical Trials Overview

Transmucosal Patch – Product Status

Transmucosal Patch – Product Description

Therakind Ltd Pipeline Products & Ongoing Clinical Trials Overview

DriDose – Product Status

DriDose – Product Description

Transire Bio Pipeline Products & Ongoing Clinical Trials Overview

OctoPatch – Product Status

OctoPatch – Product Description

Union Therapeutics AS Pipeline Products & Ongoing Clinical Trials Overview

Niclosamide Nasal Spray – Product Status

Niclosamide Nasal Spray – Product Description

University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview

Povidone-Iodine Nasal Spray – Product Status

Povidone-Iodine Nasal Spray – Product Description

University of Louisville Pipeline Products & Ongoing Clinical Trials Overview

Q-Griffithsin Nasal Spray – Product Status

Q-Griffithsin Nasal Spray – Product Description

University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview

At-Home Nasal Spray – COVID-19 – Product Status

At-Home Nasal Spray – COVID-19 – Product Description

University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview

Dapivirine + Pritelivir + Levonorgestrel 3D Printed IVR – Product Status

Dapivirine + Pritelivir + Levonorgestrel 3D Printed IVR – Product Description

Islatravir+Etonogestrel/Ethinyl Estradiol 3D Printed IVR – Product Status

Islatravir+Etonogestrel/Ethinyl Estradiol 3D Printed IVR – Product Description

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview

HerShield – Product Status

HerShield – Product Description

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview

Drug Delivery Device – Ovarian Cancer – Product Status

Drug Delivery Device – Ovarian Cancer – Product Description

University of the Witwatersrand Pipeline Products & Ongoing Clinical Trials Overview

Vagitab – Product Status

Vagitab – Product Description

University of Waterloo Pipeline Products & Ongoing Clinical Trials Overview

HIV Prevention Device – Product Status

HIV Prevention Device – Product Description

Virpax Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

AnQlar – Product Status

AnQlar – Product Description

MMS019 – Product Status

MMS019 – Product Description

VistaGen Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

PH10 Nasal Spray – Product Status

PH10 Nasal Spray – Product Description

PH80 Nasal Spray – Product Status

PH80 Nasal Spray – Product Description

VistaGen Therapeutics Inc – Ongoing Clinical Trials Overview

PH10 Nasal Spray – A Phase 1 Clinical Trial of PH10 for Major Depressive Disorder

Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview

FUSIN Device – Product Status

FUSIN Device – Product Description

Wellfully Ltd Pipeline Products & Ongoing Clinical Trials Overview

Buccal Applicator – Product Status

Buccal Applicator – Product Description

Xlear Inc Pipeline Products & Ongoing Clinical Trials Overview

Xlear Nasal Spray – COVID-19 – Product Status

Xlear Nasal Spray – COVID-19 – Product Description

Xlear Inc – Ongoing Clinical Trials Overview

Xlear Nasal Spray – COVID-19 – Clinical Efficacy of Xylitol Based Nasal Spray for the Treatment of Mild COVID-19 Infection

Zydus Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview

Nasal Spray – Spasm – Product Status

Nasal Spray – Spasm – Product Description

Glossary

Figures

Transmucosal Drug Delivery – Pipeline Products by Stage of Development

Transmucosal Drug Delivery – Pipeline Products by Segment

Transmucosal Drug Delivery – Pipeline Products by Territory

Transmucosal Drug Delivery – Pipeline Products by Regulatory Path

Transmucosal Drug Delivery – Pipeline Products by Estimated Approval Date

Transmucosal Drug Delivery – Ongoing Clinical Trials

Frequently asked questions

Transmucosal Drug Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Transmucosal Drug Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Transmucosal drug delivery reports
Medical Devices
New
Clostridium Difficile Tests Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | May 2026
Medical Devices
New
Cholesterol Tests Market Size by Segments, Share, Regulatory, Reimbursement, and…
$7,500 | May 2026
Medical Devices
New
Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | May 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Transmucosal Drug Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Transmucosal Drug Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more